These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24479625)

  • 1. The protonation state of catalytic residues in the resting state of KasA revisited: detailed mechanism for the activation of KasA by its own substrate.
    Lee W; Engels B
    Biochemistry; 2014 Feb; 53(5):919-31. PubMed ID: 24479625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarification on the decarboxylation mechanism in KasA based on the protonation state of key residues in the acyl-enzyme state.
    Lee W; Engels B
    J Phys Chem B; 2013 Jul; 117(27):8095-104. PubMed ID: 23768199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor design.
    Lee W; Luckner SR; Kisker C; Tonge PJ; Engels B
    Biochemistry; 2011 Jun; 50(25):5743-56. PubMed ID: 21615093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Insight into how β-Ketoacyl ACP Synthase I (KasA) Recognizes the Fatty Acid Chain Length of its Substrate.
    Lee W
    Chempluschem; 2024 Jul; 89(7):e202300568. PubMed ID: 37983623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis target protein.
    Jayaraman M; Rajendra SK; Ramadas K
    Gene; 2019 Dec; 720():144082. PubMed ID: 31476406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
    Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
    J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
    Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
    J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
    Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
    J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
    von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
    FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.
    Prigge ST; He X; Gerena L; Waters NC; Reynolds KA
    Biochemistry; 2003 Feb; 42(4):1160-9. PubMed ID: 12549938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes.
    Moche M; Dehesh K; Edwards P; Lindqvist Y
    J Mol Biol; 2001 Jan; 305(3):491-503. PubMed ID: 11152607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design.
    Schaefer B; Kisker C; Sotriffer CA
    J Comput Aided Mol Des; 2011 Nov; 25(11):1053-69. PubMed ID: 22076471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA.
    Kumar P; Capodagli GC; Awasthi D; Shrestha R; Maharaja K; Sukheja P; Li SG; Inoyama D; Zimmerman M; Ho Liang HP; Sarathy J; Mina M; Rasic G; Russo R; Perryman AL; Richmann T; Gupta A; Singleton E; Verma S; Husain S; Soteropoulos P; Wang Z; Morris R; Porter G; Agnihotri G; Salgame P; Ekins S; Rhee KY; Connell N; Dartois V; Neiditch MB; Freundlich JS; Alland D
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Rudraraju RS; Daher SS; Gallardo-Macias R; Wang X; Neiditch MB; Freundlich JS
    Front Cell Infect Microbiol; 2022; 12():1008213. PubMed ID: 36189349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis.
    Durairaj DR; Shanmughavel P
    Interdiscip Sci; 2019 Jun; 11(2):215-225. PubMed ID: 28856604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.
    Machutta CA; Bommineni GR; Luckner SR; Kapilashrami K; Ruzsicska B; Simmerling C; Kisker C; Tonge PJ
    J Biol Chem; 2010 Feb; 285(9):6161-9. PubMed ID: 20018879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.